Can KLEOS change how colorectal cancer trials are run for patients with limited treatment options?
CRC trials need faster evidence. KLEOS could test more therapies under one platform. Read why the model matters.
Why Bioxodes’ adaptive trial strategy could accelerate approval timelines in stroke therapeutics
Bioxodes advances BIOX-101 into pivotal trials for intracerebral hemorrhage. Find out how this strategy could reshape stroke treatment pathways.